Belgium· BE-AMP-SAM325421-00
Comtess 200 mg
A medicinal product containing entacapone, registered in Belgium by Orion.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Entacapone
- Manufacturer
- Orion
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Entacapone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCOMTANOrion Corporation, Espoo
- United StatesEntacaponeSandoz Inc
- NetherlandsComtan, 200 mg omhulde tablettenOrion Corporation
- FinlandComtanOrion Corporation
- SpainCOMTAN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULAOrion Corporation
- SwedenComtan 200 mg Filmdragerad tablettOrion Corporation
- IcelandComtanOrion Corporation
- PolandComtanOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Cyprus · Encapia
- Germany · Entacapon Hec
- Denmark · Entacapone Viatris
- Spain · Entacapona Viatris, Medapia
- Finland · Entacapone Orion Pharma
- France · Entacapone Arrow, Entacapone Viatris
- United Kingdom (Northern Ireland) · Entacapone, Entacapone Hec
- Croatia · Entakapon Hec
- Iceland · Comtan, Comtess
- Liechtenstein · Comtan, Comtess
- Lithuania · Medapia
- Malta · Medapia
- Netherlands · Encapia, Entacapone Unichem
- Norway · Comtan, Comtess
- Portugal · Entacapona Aurobindo, Medapia
- Sweden · Entacapone Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0f68e9b-6b91-4b15-8bf3-6050aed08183 GET /v1/drugs/d0f68e9b-6b91-4b15-8bf3-6050aed08183?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Comtess 200 mg",
"name_fr": "Comtess 200 mg",
"name_nl": "Comtess 200 mg",
"amp_code": "SAM325421-00",
"strengths": [
"200.0000"
],
"pack_count": 0,
"substances": [
"Entacapone"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": null
}See everything about entacapone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.